Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes

ConditionGestational Diabetes

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorUniversity of Chicago

About this trial

The aim of this study is to determine the ability of postpartum continuous glucose monitoring (CGM) for subjects with gestational diabetes (GDM) to predict dysglycemia on 4-12 week postpartum oral glucose tolerance test (OGTT).

Eligibility criteria

Qualifiers

Age greater than or equal to 18

Completed pregnancy with delivery of a live born infant(s). Pregnancies with multiple gestations will be included

No prior history of type 1 or type 2 diabetes

GDM diagnosis by standard screening at 24-28 weeks

Disqualifiers

None

Trial design

Treatments tested in this trial

Blinded Continuous Glucose Monitoring Device

Treatment groups

50 Participants

are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

University of Chicago

Lead sponsor

Source ClinicalTrials.gov